Search

everythinglearnresearchcommunity

for

Search:↓

A method was found to accurately measure spironolactone and canrenone in blood samples using liquid chromatography-mass spectrometry.

A patch with curcumin-zinc can improve hair growth and health by delivering beneficial particles to the skin, increasing hair follicles, and reversing effects of a hair loss hormone.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Nociplastic type pain, common in Chronic Overlapping Pain Conditions, is a complex, heritable trait linked to 24 unique genetic factors and 127 genes, with potential shared mechanisms in cognitive, personality, and metabolic traits.

DNA markers can predict physical traits for forensic use, but there are ethical and technical challenges.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Effective treatments for hair loss are a major focus in dermatology.

Dermal papilla cells play a key role in hair loss by responding to androgens.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Androgenetic alopecia in women needs more research and better management strategies.

DHT, a testosterone byproduct, causes male pattern baldness.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Infant skin cells may be less capable of repairing UV-induced DNA damage than adult cells.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.